New Consultation: Formulary Amendments April 2024

North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in April 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Tuesday 25th June 2024. Take part by visiting the consultations page.


New Consultation: Guidelines for the appropriate prescribing of Oral Nutritional Supplementation in the management of adults at risk of undernutrition in primary care

Following the May 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous Oral Nutritional Supplementation guidelines that currently exist across the North East and North Cumbria.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NEN

This consultation closes at 5pm on Thursday 13th June 2024. Take part by visiting the consultations page.


New consultation: 30 day TA Remdesivir and tixagevimab plus cilgavimab for treating COVID-19

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA971 Remdesivir and tixagevimab plus cilgavimab for treating COVID-19.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation closes at 5pm on Thursday 30th May 2024. Take part by visiting the consultations page.


New Consultation: NENC ICB Prescribing of Iron Supplementation for Iron Deficiency Anaemia Position Statement

Following the May 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide position statement which has been developed to support new national dosing recommendations for oral iron.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 5th June 2024. Take part by visiting the consultations page.


New Consultation: NENC Guideline – Management of Hypomagnesaemia in Adults in Primary Care

Following the May 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous Management of Hypomagnesaemia in Adults in Primary Care guidelines that currently exist in County Durham and Tees Valley.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 5th June 2024. Take part by visiting the consultations page.


New Consultation: Formulary decisions March 2024

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the draft decisions made by the NENC formulary group at their meeting in March 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 7th May 2024. Take part by visiting the consultations page.


New Consultation: Formulary Amendments March 2024

North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in March 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Monday 6th May 2024. Take part by visiting the consultations page.


New Consultation: Formulary Amendments February 2024

North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in February 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Wednesday 17th April 2024. Take part by visiting the consultations page.


New Consultation: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema. 30 day TA

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema, in the attached consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 27th March 2024. Take part by visiting the consultations page.


New Consultation: NENC SCG Ketamine for Pain in Palliative Care for patients within adult services

Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous shared care guidelines for ketamine in palliative care that currently exist in North of Tyne, Gateshead and North Cumbria.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 10th April 2024.

Take part by visiting the consultations page.